This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now
keyboard_arrow_right

Main Conference Day 2

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 2
search
7:45am - 8:10am
Registration and Coffee
8:10am - 8:15am
Chairperson’s Remarks
  • Yogesh Sanghvi, PhD - President, Rasayan Inc.
8:15am - 8:45am
Morning Spotlight Presentation: Isolation and Drying of Peptides and 0ligonucleotides – Improved Production Capacities During Large Scale Manufacturing
  • Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
Concurrent Conference Tracks
Showing 2 of 2 Streams
8:45am - 9:15am
Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents
  • Tsubasa Aoki, PhD - Researcher, Ajinomoto Co.
9:15am - 9:45am
Key Points in Oligonucleotide Formulation Development, AI/ML-Driven LNP Development, and Scale-Up: General Overview and Case Studies
  • Tomomi Sato - Associate Director, Takeda Pharmaceutical Company Limited
9:45am - 10:15am
NMA Manufacturing Process Development
  • Carter Cooperman - Research Associate II, Ionis
8:45am - 9:15am
Complete Chemical Synthesis of mRNA for Cancer Vaccine
  • Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
9:15am - 9:45am
Developing the Next Generation RSV Vaccine
  • Dong Shen, MD, PhD - CEO, RNAimmune, Inc.
9:45am - 10:15am
RNA Therapy for Asthma
  • Thomas Langenickel, MD, PhD - Chief Medical Officer, Ethris GmbH
10:15am - 10:55am
Networking Refreshment Break with Poster and Exhibit Viewing
  • Thomas Rupp - Managing Director, Axolabs Berlin GmbH
Concurrent Conference Tracks
Showing 2 of 2 Streams
10:55am - 11:00am
Chairperson’s Remarks: Track 1
  • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
11:00am - 11:30am
CMC Strategies for the Characterization of Stereopure Platform Chemistry
  • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
11:30am - 12:00pm
Template-independent Enzymatic Synthesis of Natural and Fully Modified siRNA Oligonucleotides
  • Jonathan Rittichier, PhD - Chief Scientific Officer & Co-Founder, EnPlusOne BioSciences
12:00pm - 12:30pm
Empowering Oligonucleotide Therapeutics: From Raw Materials to Manufacturing, and Advanced Delivery Solutions
  • Sirat Sikka - Senior Scientist, Applications and Innovation, Thermo Fisher Scientific
10:55am - 11:00am
Chairperson’s Remarks: Track 2
  • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
11:00am - 11:30am
Industry Perspective on the Selection of Regulatory Starting Materials for Synthetic Peptides
  • John Lopez, PhD - Associate Director Science & Technology, Novartis
11:30am - 12:00pm
Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
  • Dinesh Parmar - Associate Director Regulatory Affairs, PolyPeptide Group
12:00pm - 12:30pm
Statistical Design of Experiments in Peptide Process Development
  • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
12:30pm - 1:40pm
Networking Luncheon with Poster and Exhibit Viewing
Showing 2 of 2 Streams
1:40pm - 1:45pm
Chairperson’s Remarks: Track 1
  • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
1:45pm - 2:15pm
Drug Substance and Drug Product CMC Strategies for Start-Ups and Smaller Companies
  • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
2:15pm - 2:45pm
Oligonucleotide API Quality
2:45pm - 3:15pm
Oligonucleotide Process Validation
1:40pm - 1:45pm
Chairperson’s Remarks: Track 2
1:45pm - 2:15pm
Development of an Efficient and Scalable CSPS Process for a Mid-Sized Cyclic Peptide
  • Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
2:15pm - 2:45pm
Overcoming Aggregation Challenges in Peptide Manufacturing: Technical Approach and Case Studies
  • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
2:45pm - 3:15pm
An Inline Monitoring Method Integrated Flow Chemistry for Peptide Synthesis and Manufacturing
  • Pengyu Xu, PhD - President and Representative Director, SynCrest Inc.
3:15pm - 3:45pm
Networking Refreshment Break with Poster and Exhibit Viewing
Showing 2 of 2 Streams
3:45pm - 4:15pm
Development of a Kilogram-Scale Manufacturing Route for Guadecitabine: A Dinucleotide DNA Methyltransferase Inhibitor
  • Yogesh Sanghvi, PhD - President, Rasayan Inc.
4:15pm - 4:45pm
Analytical Strategies for RNA Therapeutics
4:45pm - 5:15pm
Oligonucleotide Purification and CMC Strategies – Increasing Efficiencies/Overcoming Challenges
  • Robert Gronke, PhD - Senior Principal Scientist, Technical Development, Biogen, Inc
3:45pm - 4:15pm
Improving Robustness and Recovery in a GLP-1 Purification Process
  • Yvan Ruland, PhD - Technology Consultant Chromatography, Sartorius Stedim Singapore
4:15pm - 4:45pm
Liquid-phase Peptide Fragment Manufacturing Technologies and Workflows
  • Adrian Amador, PhD - Director of Process Chemistry, Cambrex
4:45pm - 5:15pm
Late Breaking Presentation
5:15pm - 6:15pm
Networking Cocktail Reception with Poster and Exhibit Viewing

Please join your fellow attendees in the exhibit hall for an evening of networking while enjoying beverages and appetizers.

6:15pm - 6:20pm
Close of Day Two
Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm)
NextMain Conference Day 3
Filter
Streams
Choose Day